Accelerate Diagnostics reported -15279000 in EBITDA for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Abbott ABT:US $ 2985M 750M
Accelerate Diagnostics AXDX:US -15279000 1.01M
Becton, Dickinson and BDX:US $ 1182M 180M
Bio Rad Laboratories BIO:US $ 126.62M 48.91M
Bruker BRKR:US $ 107.6M 17.5M
Danaher DHR:US $ 2757M 20M
Exact Sciences EXAS:US $ -101.13M 28.2M
Hologic HOLX:US $ 347.9M 352.2M
Illumina ILMN:US $ 275M 145M
Pacific Biosciences Of California PACB:US $ -67.79M 7.24M
Perkinelmer PKI:US $ 420.38M 11.6M
Thermo Fisher Scientific TMO:US $ 2861M 821M